Stoke Therapeutics reported revenue of $9.32M and net income of -$62.05M for the quarter ended Jun 2026, down 32.5% year over year. This income statement covers 33 quarters of results from Jun 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue & cost | |||||||||||||||||||||||||||||||||
| Revenue | 3.00M | 3.23M | 2.90M | 3.27M | 5.15M | 2.48M | 3.31M | 2.80M | 4.22M | 4.83M | 4.89M | 22.61M | 158.57M | 13.82M | 10.63M | 1.40M | 6.23M | 9.32M | |||||||||||||||
| Operating items | |||||||||||||||||||||||||||||||||
| Research & DevelopmentR&D | 14.36M | 15.80M | 18.31M | 18.36M | 20.11M | 21.06M | 19.63M | 20.55M | 20.27M | 21.78M | 22.37M | 21.14M | 22.20M | 23.42M | 32.68M | 25.86M | 37.70M | 41.70M | 39.67M | 49.50M | |||||||||||||
| Selling, General & AdministrativeSG&A | 8.32M | 8.72M | 9.49M | 10.11M | 9.94M | 9.38M | 10.21M | 10.23M | 10.27M | 10.61M | 10.22M | 13.04M | 12.69M | 12.84M | 14.65M | 15.26M | 16.03M | 21.15M | 19.97M | 25.25M | |||||||||||||
| Other Operating ExpensesOther Opex | |||||||||||||||||||||||||||||||||
| Operating ExpensesOpex | 22.68M | 24.53M | 27.80M | 28.47M | 30.05M | 30.44M | 29.84M | 30.78M | 30.54M | 32.39M | 32.59M | 34.17M | 34.90M | 36.27M | 47.33M | 41.12M | 53.72M | 62.84M | 59.65M | 74.75M | |||||||||||||
| Operating IncomeOp. Inc | -22.68M | -24.53M | -24.80M | -25.24M | -27.15M | -27.18M | -24.69M | -33.26M | -27.23M | -29.59M | -28.37M | -29.34M | -30.00M | -13.65M | 111.24M | -27.30M | -43.09M | -61.44M | -53.42M | -65.43M | |||||||||||||
| EBIT | -22.68M | -24.53M | -24.80M | -25.24M | -27.15M | -27.18M | -24.69M | -33.26M | -27.23M | -29.59M | -28.37M | -29.34M | -30.00M | -13.65M | 111.24M | -27.30M | -43.09M | -61.44M | -53.42M | -65.43M | |||||||||||||
| Non-operating items | |||||||||||||||||||||||||||||||||
| Non Operating Interest Expenses | 0.00M | 0.00M | 0.02M | 0.02M | |||||||||||||||||||||||||||||
| Interest & Investment IncomeInt & Inv Inc | 0.04M | -0.25M | -0.52M | -0.59M | 0.99M | 1.48M | 0.58M | 0.22M | 2.65M | 2.59M | 0.02M | -0.01M | 3.54M | 2.97M | 0.05M | 3.79M | 3.46M | 3.62M | -0.66M | 3.52M | |||||||||||||
| Other Non Operating IncomeOther Non Op Inc. | 0.04M | 0.04M | 0.04M | 0.04M | 0.04M | 0.04M | 0.04M | 0.04M | 0.04M | 0.04M | -0.43M | -0.05M | 0.03M | 0.20M | 0.03M | 0.03M | 0.00M | -0.11M | 0.02M | 0.31M | |||||||||||||
| Non Operating IncomeNon Op. Inc. | 0.09M | 0.08M | 0.15M | 0.59M | 1.04M | 1.52M | 2.15M | 2.61M | 2.69M | 2.63M | 2.00M | 3.65M | 3.57M | 3.17M | 2.92M | 3.82M | 3.47M | 3.50M | 3.42M | 3.81M | |||||||||||||
| Net income details | |||||||||||||||||||||||||||||||||
| EBT | -22.64M | -24.78M | -25.31M | -25.83M | -26.15M | -25.70M | -24.11M | -33.04M | -24.58M | -27.00M | -26.37M | -25.70M | -26.43M | -10.68M | 114.16M | -23.48M | -39.62M | -57.82M | -50.00M | -61.62M | |||||||||||||
| Tax ProvisionsTaxes | 1.28M | -1.28M | |||||||||||||||||||||||||||||||
| Profit After TaxPAT | -22.60M | -24.59M | -24.65M | -24.65M | -26.54M | -25.13M | -22.55M | -30.65M | -24.54M | -26.96M | -26.37M | -25.70M | -26.43M | -10.61M | 112.88M | -23.48M | -38.35M | -58.53M | -50.00M | -62.05M | |||||||||||||
| Income from Continuing OperationsIncome (Continuing) | -22.64M | -24.78M | -25.31M | -25.83M | -26.15M | -25.70M | -24.11M | -33.04M | -24.58M | -27.00M | -26.37M | -25.70M | -26.43M | -10.68M | 112.88M | -23.48M | -38.35M | -57.82M | -50.00M | -61.62M | |||||||||||||
| Consolidated Net IncomeConsol Net Inc. | -22.64M | -24.78M | -25.31M | -25.83M | -26.15M | -25.70M | -24.11M | -33.04M | -24.58M | -27.00M | -26.37M | -25.70M | -26.43M | -10.68M | 112.88M | -23.48M | -38.35M | -57.82M | -50.00M | -61.62M | |||||||||||||
| Income towards Parent CompanyParent Net Inc | -22.64M | -24.78M | -25.31M | -25.83M | -26.15M | -25.70M | -24.11M | -33.04M | -24.58M | -27.00M | -26.37M | -25.70M | -26.43M | -10.68M | 112.88M | -23.48M | -38.35M | -57.82M | -50.00M | -61.62M | |||||||||||||
| Net Income towards Common StockholdersNet Income | -22.64M | -24.78M | -25.31M | -25.83M | -26.15M | -25.70M | -24.11M | -33.04M | -24.58M | -27.00M | -26.37M | -25.70M | -26.43M | -10.68M | 112.88M | -23.48M | -38.35M | -57.82M | -50.00M | -61.62M | |||||||||||||
| Additional items | |||||||||||||||||||||||||||||||||
| EPS (Basic) | -0.62 | -0.67 | -0.68 | -0.66 | -0.66 | -0.66 | -0.57 | -0.75 | -0.56 | -0.61 | -0.57 | -0.46 | -0.47 | -0.20 | 1.95 | -0.40 | -0.65 | -0.98 | -0.79 | -0.93 | |||||||||||||
| EPS (Diluted) | -0.62 | -0.67 | -0.68 | -0.66 | -0.67 | -0.66 | -0.57 | -0.75 | -0.56 | -0.61 | -0.57 | -0.46 | -0.47 | -0.20 | 1.90 | -0.40 | -0.65 | -0.98 | -0.79 | -0.93 | |||||||||||||
| Shares Outstanding | 36.76M | 36.74M | 37.45M | 39.26M | 39.42M | 38.90M | 42.54M | 44.19M | 44.27M | 43.99M | 46.25M | 55.77M | 56.34M | 54.01M | 57.86M | 58.35M | 58.61M | 59.22M | 63.06M | 66.02M | |||||||||||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 36.71M | 36.74M | 37.45M | 39.26M | 39.26M | 38.90M | 42.54M | 44.19M | 44.27M | 43.99M | 46.25M | 55.77M | 56.34M | 54.01M | 59.40M | 58.35M | 58.61M | 59.22M | 63.06M | 66.02M | |||||||||||||
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 36.78M | 36.90M | 39.04M | 39.38M | 39.43M | 39.44M | 44.18M | 44.20M | 44.29M | 45.92M | 46.50M | 52.31M | 52.94M | 54.03M | 54.60M | 54.72M | 55.12M | 58.92M | 62.24M | 62.40M | |||||||||||||
| EBITDA | -22.68M | -24.53M | -24.80M | -25.24M | -27.15M | -27.18M | -24.69M | -33.26M | -27.23M | -29.59M | -28.37M | -29.34M | -30.00M | -13.65M | 111.24M | -27.30M | -43.09M | -61.44M | -53.42M | -65.43M | |||||||||||||
| Interest ExpensesInt Expense | 0.00M | 0.00M | 0.02M | 0.02M | |||||||||||||||||||||||||||||
| Tax Rate | 1.12% | 3.23% |